Fuxiang Yu

628 total citations
27 papers, 460 citations indexed

About

Fuxiang Yu is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Fuxiang Yu has authored 27 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Hepatology and 7 papers in Cancer Research. Recurrent topics in Fuxiang Yu's work include Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and RNA modifications and cancer (4 papers). Fuxiang Yu is often cited by papers focused on Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and RNA modifications and cancer (4 papers). Fuxiang Yu collaborates with scholars based in China and United States. Fuxiang Yu's co-authors include Qiyu Zhang, Qiyu Zhang, Gang Chen, Qiandong Zhu, Zhengping Yu, Yihu Zheng, Yongfeng Chen, Yunfeng Shan, Gang Chen and Jingfeng Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and RSC Advances.

In The Last Decade

Fuxiang Yu

27 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fuxiang Yu China	12	196	121	101	100	81	27	460
Hélène Dubois‐Pot‐Schneider France	8	191 1.0×	81 0.7×	114 1.1×	139 1.4×	68 0.8×	16	432
Chen Zong China	16	291 1.5×	149 1.2×	116 1.1×	153 1.5×	125 1.5×	22	689
Kuang‐Tzu Huang Taiwan	14	285 1.5×	149 1.2×	58 0.6×	50 0.5×	101 1.2×	38	528
Jiequn Li China	11	153 0.8×	83 0.7×	68 0.7×	52 0.5×	36 0.4×	30	292
Joanne Chiu China	13	123 0.6×	89 0.7×	62 0.6×	55 0.6×	241 3.0×	52	516
Sarani Ghoshal United States	10	201 1.0×	117 1.0×	62 0.6×	120 1.2×	115 1.4×	15	529
Tümen Mansuroglu Germany	10	145 0.7×	38 0.3×	126 1.2×	133 1.3×	83 1.0×	14	395
Xianli He China	10	242 1.2×	143 1.2×	52 0.5×	32 0.3×	142 1.8×	19	469
Xiaojie Gan China	12	143 0.7×	87 0.7×	50 0.5×	55 0.6×	64 0.8×	23	334

Countries citing papers authored by Fuxiang Yu

Since Specialization

Citations

This map shows the geographic impact of Fuxiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuxiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuxiang Yu more than expected).

Fields of papers citing papers by Fuxiang Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuxiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuxiang Yu. The network helps show where Fuxiang Yu may publish in the future.

Co-authorship network of co-authors of Fuxiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Fuxiang Yu. A scholar is included among the top collaborators of Fuxiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuxiang Yu. Fuxiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xiaoxiao, Xiaoxuan Wang, Fuxiang Yu, et al.. (2024). Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes. Translational Oncology. 52. 102232–102232. 1 indexed citations

Yu, Bo, Yaping Li, Fuxiang Yu, et al.. (2022). LINC01006 and miR-3199 Serve as Novel Markers of Poor Prognosis in Colon Cancer and Regulate Cell Proliferation, Migration and Invasion. SHILAP Revista de lepidopterología. 1 indexed citations

Yu, Fuxiang, et al.. (2021). A scoring system for gallbladder polyps based on the cross-sectional area and patient characteristics. Asian Journal of Surgery. 45(1). 332–338. 7 indexed citations

Yu, Fuxiang, et al.. (2021). A narrative review of the antitumor studies of solanine. Translational Cancer Research. 10(3). 1578–1582. 15 indexed citations

Sun, Yunpeng, Qiandong Zhu, Mengtao Zhou, et al.. (2018). Restoration of miRNA‑148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β‑catenin signaling pathway via downregulating maternally expressed gene‑3. Experimental and Therapeutic Medicine. 17(1). 639–648. 16 indexed citations

Guo, Pengyi, Yi Wang, Fang Wu, et al.. (2017). Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma. Oncogene. 37(9). 1220–1236. 54 indexed citations

Zhang, Qiyu, et al.. (2017). Low concentrations of bilirubin inhibit activation of hepatic stellate cells in vitro. Molecular Medicine Reports. 15(4). 1647–1653. 9 indexed citations

Wang, Yi, Haitao Yu, Yunfeng Shan, et al.. (2016). EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway. Journal of Experimental & Clinical Cancer Research. 35(1). 65–65. 25 indexed citations

Jin, Weidong, Lei Chen, Yunxiao Zhang, et al.. (2016). Long non-coding RNA TUC338 is functionally involved in sorafenib-sensitized hepatocarcinoma cells by targeting RASAL1. Oncology Reports. 37(1). 273–280. 53 indexed citations

10.

Zhou, Qi, et al.. (2016). Development and characterization of novel microsatellite markers for Ginkgo biloba using 454 pyrosequencing. Genetics and Molecular Research. 15(1). 2 indexed citations

11.

Xu, Shihao, Jingfeng Chen, Yuanping Hu, et al.. (2016). Application of ultrasound‐guided percutaneous intrahepatic portal vein catheterization with antibiotic injection for treating unliquefied bacterial liver abscess. Hepatology Research. 47(3). E187–E192. 2 indexed citations

12.

Zhong, Yongde, et al.. (2016). Expressed sequence tag analysis of functional genes associated with adventitious rooting in Liriodendron hybrids. Genetics and Molecular Research. 15(2). 5 indexed citations

13.

Sun, Yunpeng, Fuxiang Yu, Wenjun Yang, et al.. (2016). Discovery of a novel human lactate dehydrogenase A (LDHA) inhibitor as an anti-proliferation agent against MIA PaCa-2 pancreatic cancer cells. RSC Advances. 6(28). 23218–23222. 4 indexed citations

14.

Yu, Fuxiang, et al.. (2015). Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion. World Journal of Surgical Oncology. 13(1). 52–52. 27 indexed citations

15.

Yu, Fuxiang, et al.. (2015). Inhibition of pancreatic stellate cell activity by adipose-derived stem cells. Hepatobiliary & pancreatic diseases international. 14(2). 215–221. 4 indexed citations

16.

Xu, Meng, et al.. (2015). Development of novel chloroplast microsatellite markers for Ginkgo biloba. Genetics and Molecular Research. 14(3). 7715–7720. 6 indexed citations

17.

Yu, Fuxiang, Li Wan, Chunlei Dai, et al.. (2013). Adipose-derived mesenchymal stem cells inhibit activation of hepatic stellate cells in vitro and ameliorate rat liver fibrosis in vivo. Journal of the Formosan Medical Association. 114(2). 130–138. 45 indexed citations

18.

Yu, Fuxiang, et al.. (2012). Effectiveness and Safety of Preoperative Percutaneous Transhepatic Cholangiodrainage With Bile Re-infusion in Patients With Hilar Cholangiocarcinoma: A Retrospective Controlled Study. The American Journal of the Medical Sciences. 346(5). 353–357. 9 indexed citations

19.

Yu, Fuxiang, et al.. (2012). Inhibition of hepatic stellate cell activation and liver fibrosis by fat-specific protein 27. Molecular and Cellular Biochemistry. 369(1-2). 35–43. 11 indexed citations

20.

Zheng, Yihu, et al.. (2011). The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 137(12). 1813–1822. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact